Skip to content

US Senator makes ‘the most suspicious congressional stock trade in months’ 

US Senator makes 'the most suspicious congressional stock trade in months' 

Recently, Congressional stock trading has faced heightened scrutiny, fueled by concerns over potential conflicts of interest and the unfair advantage that lawmakers may wield in financial markets. 

The spotlight on this issue intensified when US senators introduced the ‘Ban Congressional Stock Trading Act,’ a proposed legislation aiming to mandate members of Congress, their spouses, and dependent children to either place their stocks in a blind trust or divest their holdings. 

While the act is yet to be approved, issues associated with Congressional stock trading continue. On Monday, November 20, one US senator made a particularly questionable trade, drawing significant public attention. 

The trade

On November 8, Senator Tina Smith invested $250,000 in shares of Tactile Systems Technology (NASDAQ: TCMD), a company that makes medical devices for treating lymphedema and chronic swelling and healing of venous ulcers.

Tactile Systems is a small healthcare stock, and Senator Smith sits on the Senate Committees on Health. The company is based in Senator’s home state of Minnesota and has received millions of dollars worth of government contracts so far, even though it is a small company with a market cap of less than $300 million.

In just two weeks after Smith’s investment, TCMD gained more than 19%, according to Quiver Quantitative

The popular X account, which regularly tracks stock market moves by US representatives, said this is “the most suspicious congressional stock trade I’ve seen in months.”

Historically, TCMD has been a volatile stock, Quiver noted, and this surge is its biggest two-week increase in months.

Congress betting against the US economy

The revelation of Smith’s fishy investment in TCMD comes amid a fascinating period when it comes to Congressional stock trading. 

Namely, US representatives have been taking a notably bearish stance on the domestic economy in the stock market. In 2023, approximately 64% of their total trading volumes were attributed to sales. 

This marks a departure from historical norms, where the percentage of trading volume from sales by Congress members ranged between 44% and 56%. The recent trend suggests a noteworthy shift in the trading behavior of US politicians towards a more pessimistic outlook in recent months.

Buy stocks now with Interactive Brokers – the most advanced investment platform


Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk.

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD

Read Next:

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account? Sign In

Services

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.